US Stock MarketDetailed Quotes
SLRX Salarius Pharmaceuticals
- 0.5010
- -0.0266-5.04%
Close May 3 16:00 ET
2.39MMarket Cap-130P/E (TTM)
0.5276High0.4900Low20.11KVolume0.5140Open0.5276Pre Close10.28KTurnover0.50%Turnover RatioLossP/E (Static)4.78MShares2.310052wk High0.45P/B2.03MFloat Cap0.430052wk Low--Dividend TTM4.05MShs Float15512.4938Historical High--Div YieldTTM7.13%Amplitude0.4300Historical Low0.5110Avg Price1Lot Size
About Salarius Pharmaceuticals Company
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.
Company Profile
SymbolSLRX
Company NameSalarius Pharmaceuticals
Listing DateJan 29, 2015
Issue Price16.00
Founded2014
CEOMr. David J. Arthur
MarketNASDAQ
Employees2
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2450 Holcombe Boulevard,Suite X
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77021
Phone1-832-834-6992
Websitehttp://salariuspharma.com
Company Executives
- Name
- Position
- Salary
- David J. Arthur
- Chief Executive Officer
- 941.02K
- Mark J. Rosenblum
- Executive Vice President, Finance, Chief Financial Officer and Principal Accounting Officer
- 494.55K
- Dr. William K. McVicar, PhD
- Chairman of the Board
- 85.92K
- Jonathan I. Lieber, M.B.A.
- Independent Director
- 61.17K
- Tess Burleson
- Independent Director
- 71.54K
- Dr. Paul Lammers,M.D.
- Lead Independent Director
- 85.04K
- Dr. Bruce McCreedy, PhD
- Independent Director
- 49.67K
- Arnold C. Hanish
- Independent Director
- 73.42K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg